Article Information
History
- August 11, 2022.
Article Versions
- You are currently viewing Version 1 of this article (August 11, 2022 - 10:44).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Imran Khan1,
- Brunilde Gril1,#,
- Anurag Paranjape1,*,
- Christina Burks2,
- Christina Robinson3,
- Simone Difilippantonio3,
- Wojciech Biernat4,
- Michał Bieńkowski4,
- Rafał Pęksa4,
- Renata Duchnowska5,
- Jacek Jassem6,
- Priscilla K. Brastianos7,
- Philippe Metellus8,
- Emilie Bialecki8,
- Carolyn C. Woodroofe9,
- Haitao Wu9,
- Rolf Swenson9 and
- Patricia S. Steeg1,$
- 1Women’s Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD
- 2Electron Microscopy Laboratory, Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research (FNLCR), Frederick MD
- 3Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research (FNLCR), Frederick, MD
- 4Department of Pathology, Medical University of Gdańsk, 7 Dębinki St, 80-211, Gdańsk, Poland
- 5Department of Oncology, Military Institute of Medicine, Warsaw, Poland
- 6Department of Oncology and Radiotherapy, Medical University of Gdańsk, Poland
- 7Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
- 8Ramsay Général de Santé, Hôpital Privé Clairval, Département de Neurochirurgie and Aix-Marseille Université, Institut de Neurophysiopathologie – UMR 7051, Marseille, France
- 9Chemistry and Synthesis Center, National Heart, Lung and Blood Institute, NIH, Bethesda, MD
- ↵$Corresponding Author: Patricia S. Steeg, steegp{at}mail.nih.gov, Building 37, Room 1126, NCI, NIH, Bethesda MD 20892 USA